BOSTON - A new RSV vaccine shows promise in preventing severe respiratory illness in seniors and infants. RSV is a virus that not only causes serious respiratory infection in infants, but in older adults as well. A new study in the New England Journal of Medicine found ...
CBS News Baltimore CBS News Bay Area CBS News Boston CBS News Chicago CBS News Colorado CBS News Detroit CBS News Los Angeles Keller @ Large Boston City Councilor on housing crisis in Ma... 10:01Jan 19, 2025 Keller: Solving T's financial problems may re... ...
ABC News chief medical correspondent Dr. Jen Ashton talks about promising data that shows an RSV vaccine can be used for younger adults with underlying medical conditions.
[03:30.96]In May, the FDA approved two RSV vaccines for older adults [03:37.36]from GlaxoSmithKline and Pfizer. [03:41.84]In August, the FDA is expected to make a decision [03:46.36]on approving Pfizer's vaccine for pregnant wo...
An RSV vaccine developed by Pfizer provides safe and effective protection in both seniors and newborns, clinical trial results show.
After years of setbacks for RSV research, drugmakers have made big improvements this year. In May, the FDA approved two RSV vaccines for older adults from GlaxoSmithKline and Pfizer. In August, the FDA is expected to make a decision on approving Pfizer’s vaccine for pregnant women. The aim...
In people 60 and older, the vaccines reduced the risk of severe RSV by about 86%. How long will the new RSV vaccine protect elders and infants from RSV? For adults 60 and older, RSV vaccines are showing continued protection even two years after immunization. Based on this, the U.S. Ce...
“Most of us never saw this much flu and RSV,” Maldonado said. She has seen “hundreds if not thousands of kids with RSV, many with no underlying conditions” who became seriously ill. While there’s no vaccine for infants and young children yet, it might be available this fal...
RSV Vaccine Proves 75% Effective Against Hospitalization in Older Adults, According to New CDC DataHalsey, GracePatient Care (Online)
RSV-related childhood mortality is highest in developing countries, says Falsey. More treatment measures are needed, especially paediatric options. In July, Moderna submitted to US, European and Australian agencies for approval of an mRNA RSV vaccine for adults over 60, and they are working on a...